Nancy Lee

Vice Chair, Member, Mskcc Director of Head and Neck Cancer; Director of proton therapy

[Dr Sania @iamsania_AI]

🚨 BREAKING: Claude can now turn 40+ research papers into a structured research system.

Here are 9 powerful prompts to build literature reviews, map knowledge, identify research gaps, and synthesize evidence faster.

(🔖 Save this.)

[Michael Topf MD, MSCI @TopfHNS]

Thanks to @xrtGenomics for highlighting the exciting work for #HPVassociated oropharynx cancer patients at @MSKCancerCenter at the #NextGenHN meeting #30gy #FMISO @imrtlee @VanderbiltENT

[Albert Koong, MD PhD @ACKoongMDPhD]

Randomized data shows PFS and OS benefit for SBRT/SABR for panc cancer. Congrats to Australasian GI Trials Group for completing this study. #radonc @Aiims1742 @TedHong9 @Dan_ChangMD @PrajnanDasMD @MikeChuongMD

https://t.co/7pDmm4nyXb

[Nancy Lee @imrtlee]

@EChrisDee @chr_huang @MSKCancerCenter @MSK_RadOnc @xrtGenomics @JournalCancer @ACSNews @nyproton @MiamiCancerInst Congrats to Chris Dee to report this prospective proton reRT trial for recurrent HNC. Important evidence for our field.

[Nancy Lee @imrtlee]

@DavidSherMD @EChrisDee @chr_huang @MSKCancerCenter @MSK_RadOnc @xrtGenomics @JournalCancer @ACSNews @nyproton @MiamiCancerInst I tell all surgeons do not biopsy the area that is twice radiated ever.

[Edward Christopher "Chris" Dee, MD @EChrisDee]

🧵 Excited to share our multicenter, prospective phase 2 trial of proton re-irradiation for people with recurrent head & neck cancer, now in @JournalCancer

Grateful to Dr @IMRTLee @xrtGenomics @DrPaulRomesser and team for the opportunity to write 🙏

🔗 https://t.co/UNSRCe132P

[Albert Koong, MD PhD @ACKoongMDPhD]

The multi-talented Dr. Jim Allison showcases his other skills after the JPAI symposium. What an amazing day of science and music!@UTMDAnderson @NobelPrize #endcancer

[Pimul Sarikh @PimulSarikh]

Hee hee. #radonc

[Milit Patel @militspatel]

Grateful to see our Perspective out in @BMJ_HCI on co-creation and LMIC-led AI for global health. Thank you to my wonderful coauthors.

@EChrisDee @imrtlee @pike_lab @IyengarPuneeth

https://t.co/JAGMxHITaw

[James Chow @jameschowch]

How far should we pursue curative-intent treatment in de novo metastatic #NPC?

Delighted to have contributed to this newly published international consensus guideline @TheLancetOncol.

🧵1/5

[James Chow @jameschowch]

📍Evidence gaps remain. Curative intent is not a promise of cure. Dedicated prospective trials are needed to refine patient selection and treatment choices.

Beyond “metastatic or not?”, we should ask: "could we offer this patient a realistic chance of long-term survival?"

🧵4/5

[C. Jillian Tsai, MD, PhD @CJTsaiMDPhD]

👋 Congrats to @fifimcdrmh and investigators!
🫁 SARON (RCT Ph II, n=140) @myESMO #ESMO26 Oligomet driver-neg NSCLC- SACT ± consolidative RT to all sites
• mPFS 13.9 vs 8.9 mo (HR 0.64)
• 12-mo local failure 13% vs 39.5%
• OS HR 0.99 ❌ no diff

[Albert Koong, MD PhD @ACKoongMDPhD]

The Tims send greetings from Madrid! Join us for another episode of “Live: Behind the Breakthroughs” Monday at 10 am CST. We will be talking about the latest data from #ESMO2026 @UTMDAnderson #endcancer

[Himanshu Nagar @HimanshuNagarMD]

A proud moment for our family!

Congratulations to my wife, @PriyaNori, on receiving the 2026 @IDSAInfo Foundation Inclusive Leadership Award @IDWeekmtg. https://t.co/lYhahc9mzj

Her commitment to mentorship and opening doors for the next generation of ID physicians makes this recognition especially meaningful.

The Nori Foundation Early-Career ID Research Award supports visa-sponsored international medical graduates pursuing ID research. Applications open in January 2027.

Please share with colleagues who may be eligible: https://t.co/JGGGYTDpBO

[Nancy Lee @imrtlee]

@ACKoongMDPhD San Francisco ❤️❤️

[Amir Safavi @safaviaa]

Now in @JAMAOnc:

We report 5y outcomes post 30 Gy elective RT (total 70 Gy CCRT) for 276 pts w/ HPV-related OPC #hncsm at @MSKCancerCenter #radonc

LRC 97.0%
OS 90.8%
PFS 85.9%
DMFS 91.2%

@imrtlee @xrtGenomics @seanmmcbride @CJTsaiMDPhD @EChrisDee

👉 https://t.co/FgCBjwkkq4

[Edward Christopher "Chris" Dee, MD @EChrisDee]

Led by Drs @SafaviaA and @IMRTLee in @JAMAOnc: Can we safely reduce elective radiation dose in HPV+ oropharyngeal cancer?

Our study provides 5-yr evidence supporting elective nodal de-escalation to just 30 Gy, while maintaining excellent disease control.

https://t.co/SRS318z2xj

[Edward Christopher "Chris" Dee, MD @EChrisDee]

Sharing our latest in @AmJClinOncol!

Does how far a patient lives from a cancer center influence whether they receive radiation—and what type?

We studied this in people with WHO grade 2–3 meningioma.

Proud of @gorantla_nipun for leading this work!

https://t.co/ucbII1cyNd

[Edward Christopher "Chris" Dee, MD @EChrisDee]

📜 Our latest in @JAMANetworkOpen, led by @AdvaitThaploo @KaitlynLapen @FumikoChino

Financial Toxicity Among Disaggregated Asian American Cancer Survivors

Are we missing important disparities by grouping Asian Americans together?

Our data say YES

🔗 https://t.co/ewUcceHIPe

[Alexander Allen, MD @alex_allen1993]

Excellent, must-read summary of the TORPEdO and MDACC trials